Please login to the form below
PBMs
This page shows the latest PBMs news and features for those working in and with pharma, biotech and healthcare.
FDA clears generic of Daraprim, the ‘poster drug’ for price-gouging
Other attempts to break the Daraprim monopoly included pharmacy benefit manager (PBM) Express Scripts forging a partnership with compounding pharmacy company Imprimis to provide a low-cost alternative.
Latest news
-
AbbVie/Allergan's merger faces public opposition
Drugmakers have blamed high pricing on rebates demanded by PBMs for inclusion in formularies, while PBMs have insisted this is not the case and that all inclusion decisions are based on
-
Novo follows Sanofi, Lilly with insulin price cut in US
They denied they were responsible, pointing to the complexity of the health insurance system in the US and – in particular – pharmacy benefit managers (PBMs), which the drugmakers claim have a vested ... With PBMs blaming manufacturers for the
-
White House unveils plans to reimport medicines from Canada
This would allow pharma companies to bypass contracts with pharmacy benefit managers (PBMs), but is unlikely to have any takers from pharma, which has been quick to express its strong opposition ... PhRMA had been in support of proposals to ban the
-
PhRMA opposed to Senate drug price control plans
Other measures are also included, including an increase in the maximum rebate allowed under Medicaid, and forcing pharmacy benefit managers (PBMs) to disclose information on the discounts they are negotiating. ... PhRMA said in a statement that the
-
Another setback on pricing as Trump drops rebate plans
Shares in pharmacy benefit managers (PBMs) such as Cigna, UnitedHealth and CVS Health leaped upwards after it became clear that the measure – billed by the Department of Health and Human Services ... AARP. It was one of the few measures outlined by
More from news
Approximately 1 fully matching, plus 37 partially matching documents found.
Latest Intelligence
-
Eliminating pharmaceutical rebates, is this déjà vu?
A 2019 report by the GAO (US Government Accountability Office) found that PBMs, or the PBM arm of integrated organisations, were retaining less than 1% of the Medicare Part D rebates ... Whereas in 2012, a survey conducted of health plans and PBM
-
The fight for affordable insulin
In April, in response to growing outrage over the problem (and the wider issue of rising drug prices), executives from pharma companies, pharmacy benefit managers (PBMs) and health insurers were hauled ... We know a lot of their messages align with those
-
The handover: Pfizer reshapes itself for a new era
Read has instead reiterated his support for ending the US rebate system between pharma and pharmacy benefit managers (PBMs) as the best way of lowering prices for patients.
-
The rise of vertical integration in the US payer landscape
But how can manufacturers respond to these new customers? PBM within a payer: Anthem. ... Third, IngenioRx’s goals may differ from those of typical carve-out PBMs.
-
Can new data aggregators shift the balance of power away from pharma?
In the latter case think biotechs and PBMs.) The industry’s strategic response has usually been jump-started by M&A, since organic growth driven by R&D-led changes were
More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Lead Copywriter
-
Competitive
-
Medical Editor
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
-
Healthcare Account Director
-
Competitive
- PHE study finds people who have had COVID-19 can still transmit the virus
- Sinovac’s COVID-19 vaccine appears safe in older adults
- PHE study finds people who have had COVID-19 can still transmit the virus
- GSK’s PD-1 inhibitor dostarlimab shows updated promise in dMMR solid tumours
- New study identifies drugs that are safe to use in COVID-19 treatment
- AZ seeks EU approval for its Oxford University-partnered COVID-19 vaccine
- Onyx Health Celebrates Its 10th Anniversary with Five New Hires
- Merck’s appeal to restore hepatitis C patent verdict against Gilead fails
- Moderna cooperating with investigation into possible COVID-19 vaccine allergic reactions
- Trial combining British and Russian COVID-19 vaccines could begin in February
- New Oxford research institute established to tackle antimicrobial resistance
- EU proposes vaccine-sharing mechanism with low-income countries
PMHub
EPG Health
REACH, ENGAGE & MEASURE - Accomplish meaningful HCP engagement via Medthority, our trusted independent medical website. Support education and treatment...
Latest intelligence
- Sourcing R&D innovation: why pharma companies need to evolve their business models
- Recent years have seen a significant shift in drug development to specialty areas...
- 2020 - a year to remember or forget?
- 2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
- The search for effective drug treatments for COVID-19
- PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
Quick links
Infographics
